Drugs / Cresto
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01415466 | Aug → Sep 2011 | — | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2016-04-11 | Daewoong Pharmaceutical Co. LTD. | Daewoong Pharmaceuticals and AstraZeneca Korea jointly sell ‘Cresto’, treatment for hyperlipidemia daewoong.co.kr ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cresto | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01415466 ↗ |